Israeli foodtech startup Maolac has raised $3.2 million in a Seed funding round to develop technology to harnesses the benefits found in breast milk to create superfood by extracting the same proteins from bovine colostrum or plant-based analogsand. The round was led by investment platform OurCrowd and also included the participation of The Kitchen FoodTech Hub founded by the Strauss Group, The Food Tech Lab, VentureIsrael, NEOME, and Mediterranean Towers Ventures.
Maolac was founded in 2018 by biomedical engineer Maya Ashkenazi-Otmazgin, immunity expert Dr. Ariel Orbach, and Eli Lerner. Maya was nursing her first child when she thought of the idea of harnessing the health benefits of breast milk to create a superfood, which would be available to everyone.
Using computational biology, Maolac can identify and extract functional proteins from bovine colostrum. Maolac claims to also be the first organization in the world to create functional milk proteins from bovine colostrum, a nutrient-rich milky fluid that comes from the udder of cows in the first few days after giving birth, and are 95% equivalent to those found in human breast milk.
Maolac will use the seed funding to build a state-of-the-art facility that will feature small-scale production capabilities.